Skip to main content
Newaj M. Abdullah
( out of 72 reviews )

Newaj M. Abdullah, MD

Languages spoken: Bengali, English, Hindi, Urdu
  • Specialties

    • Anesthesiology

    Board Certification

    National Board of Medical Examiners

    Patient Rating

    4.8 /5
    ( out of 72 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 24, 2024
    PAIN MANAGEMENT CENTER

    Outstanding doctor! Really cares about finding solutions and thinks carefully about treatment options.

    April 11, 2024
    PAIN MANAGEMENT CENTER

    I thought he was great! He really knew his stuff, he was thorough, and he was kind.

    April 04, 2024
    PAIN MANAGEMENT CENTER

    Dr Abdullah cares about my pain when others blew me off because I have so many ailments.

    February 29, 2024
    PAIN MANAGEMENT CENTER

    Great Doctor Abdullah is a very understanding on me with my attitude and Pain level. I have good & bad days, with my T.B.I.. Very understanding Doctor. I thank him

    February 29, 2024
    PAIN MANAGEMENT CENTER

    Dr. Abdullah is accomplished in his field of practice. At University of Utah Pain Management Center he is supported by a top notch staff and facility infrastructure. The infrastructure includes a user friendly online communication and records system that can handle complex schedule adjustments. Dr. Abdullah treats patients of all backgrounds with dignity and respect and will assist in accomplishing treatments for patients with special needs. Among other procedures he performs Radio Frequency Ablations as he did on me. This modality is available with sedation at the PMC unlike numerous alternative providers in Utah. I highly recommend this provider on the basis of his professionalism his support environment and his tested skill set.

    February 23, 2024
    PAIN MANAGEMENT CENTER

    Dr newaji was very educated on what I needed and explained everything very clearly so I understood exactly what was going on and how we were to proceed.

    February 15, 2024
    PAIN MANAGEMENT CENTER

    Helpful, compassionate, knowledgeable, friendly, nice, interesting - all positives!

    February 08, 2024
    PAIN MANAGEMENT CENTER

    he took the time to answer my questions and concerns, and he made me feel like he actually wanted to help me and that I wasn¿t some kind of druggie that needed pain meds. He actually understood the pain I was in and took it seriously

    February 07, 2024
    PAIN MANAGEMENT CENTER

    Dr. Abdullah listened carefully and, given his after visit notes, understood what I was trying to explain. He explained options but did not try to pressure into treatment courses.

  • Board Certification and Academic Information

    Academic Departments Anesthesiology -Primary
    Board Certification
    National Board of Medical Examiners

    Education history

    Residency Anesthesiology - Baylor College of Medicine Chief Resident
    Anesthesiology - Baylor College of Medicine Resident
    Residency Urology - Geisinger Commonwealth School of Medicine Resident
    Minimally Invasive Surgery - Wayne State University School of Medicine Clinical Research Fellow
    Professional Medical Medicine - Wayne State University School of Medicine M.D.
    Pharmaceutical Sciences and Engineering - University of Michigan College of Pharmacy College of Engineering B.S.E.
    Undergraduate Chemical Engineering - Stanford University B.S.E.

    Selected Publications

    Journal Article

    1. Gish B, Langford B, Sobey C, Singh C, Abdullah N, Walker J, Gray H, Hagedorn J, Ghosh P, Patel K, Deer T (2023). Neuromodulation for the management of chronic pelvic pain syndromes: A systematic review. Pain Pract.
    2. Abdullah N, Sindt JE, Whittle J, Anderson JS, Odell DW, Mahan M, Brogan SE (2023). Impact of neuromodulation on opioid use, adjunct medication use, and pain control in cancer-related pain: a retrospective case series. Pain Med. 2023 Jul 5;24(7):903-906. doi: 10.1093/pm/pnad001. PMID: ; PMCID: PMC10321759. Pain Med, 24(7), 903-906.
    3. Abdullah NM, Jenkinson RH, Deer TR, Hagedorn, JM (2023). Treatment of chest wall pain syndrome from oncologic etiology of with neuromodulation: A narrative review. Interventional Pain Medicine, 2(2), 100225.
    4. Sayed D, Naidu RK, Patel KV, Strand NH, Mehta P, Lam CM, Tieppo Francio V, Sheth S, Giuffrida A, Durkin B, Khatri N, Vodapally S, James CO, Westerhaus BD, Rupp A, Abdullah NM, Amirdelfan K, Petersen EA, Beall DP, Deer TR (2022). Best Practice Guidelines on the Diagnosis and Treatment of Vertebrogenic Pain with Basivertebral Nerve Ablation from the American Society of Pain and Neuroscience. J Pain Res, 14(15), 2801-2819.
    5. Hagedorn JM, Engle AM, George TK, Karri J, Abdullah N, Ovrom E, Bocanegra-Becerra JE, DSouza RS (2022). An overview of painful diabetic peripheral neuropathy: Diagnosis and treatment advancements. Diabetes Res Clin Pract, 188(109928).
    6. Abdullah N, Muir C, Eldrige JS, Pingree MJ, Hagedorn JM (2019). Peri-procedural Management of Implanted Spinal Cord Stimulators in Patients Undergoing Radiofrequency Ablation: A Case Report and Manufacturer-Specific Recommendations. Pain Pract, 20(4), 405-411. (Read full article)
    7. Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, Johnson M, Mass A, Zargar H, Kaouk J, Allaf M, Bhayani S, Stifelman M, Rogers C (2016). Use of the Satinsky clamp for hilar clamping during robotic partial nephrectomy: indications, technique, and multi-center outcomes. J Robot Surg, 11(1), 47-51. (Read full article)
    8. Abdullah N, Rahbar H, Barod R, Dalela D, Larson J, Johnson M, Mass A, Zargar H, Allaf M, Bhayani S, Stifelman M, Kaouk J, Rogers C (2016). Multicentre outcomes of robot-assisted partial nephrectomy after major open abdominal surgery. BJU Int, 118(2), 298-301. (Read full article)
    9. Abdullah N, Dalela D, Barod R, Larson J, Johnson M, Mass A, Zargar H, Allaf M, Bhayani S, Stifelman M, Kaouk J, Rogers C (2015). Robotic partial nephrectomy for renal tumours in obese patients: Perioperative outcomes in a multi-institutional analysis. Can Urol Assoc J, 9(11-12), E859-62. (Read full article)
    10. Obi AT, Pannucci CJ, Nackashi A, Abdullah N, Alvarez R, Bahl V, Wakefield TW, Henke PK (2015). Validation of the Caprini Venous Thromboembolism Risk Assessment Model in Critically Ill Surgical Patients. JAMA Surg, 150(10), 941-8. (Read full article)
    11. Abdullah NM, Lakshmanan Y (2014). We can rebuild it: reconstructive solutions for structural urologic diseases. Adv Chronic Kidney Dis, 22(4), 320-4. (Read full article)
    12. Sood A, Abdullah N, Abdollah F, Abouljoud MS, Trihn QD, Menon M, Sammon JD (2015). Nationwide Incidence of Kidney Transplantation–Resolved and Persistent Racial Disparities: Analysis of the United Network of Organ Sharing Data Registry 1998-2011. JAMA Intern Med, 175(10), 1716-8.
    13. Pannucci CJ, Obi A, Alvarez R, Abdullah N, Nackashi A, Hu HM, Bahl V, Henke PK (2014). Inadequate venous thromboembolism risk stratification predicts venous thromboembolic events in surgical intensive care unit patients. J Am Coll Surg, 218(5), 898-904. (Read full article)
    14. Obi AT, Alvarez R, Pannucci C, Shipra A, Nackashi A, Abdullah N, Bahl V, Naplitano L, Wakefield TW, Henke PK (2013). Venous Thromboembolism Risk Assessment Scoring in the Critically Ill: The Impact of Misclassification. J Vasc Surg, 57(5), 74S-5S.
    15. Abdullah NM, Kachman M, Walker A, Hawley AE, Wrobleski SK, Myers DD, Strahler JR, Andrews PC, Michailidis GC, Ramacciotti E, Henke PK, Wakefield TW (2008). Microparticle surface protein are associated with experimental venous thrombosis: a preliminary study. Clin Appl Thromb Hemost, 15(2), 201-8. (Read full article)
    16. Abdullah NM, Rosania GR, Shedden K (2009). Selective targeting of tumorigenic cancer cell lines by microtubule inhibitors. PLoS One, 4(2), e4470. (Read full article)
  • News & Podcasts